Continual vs. Routine Home Blood Pressure Monitoring and Management in Diverse Community Practice: CHANGE-BP
Key facts
- Who runs it
- Aktiia SA
- Where
- Portland, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 15 Dec 2024
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Aktiia Device
- Upper arm cuff
- Record updated
- 18 February 2025
- Why it stopped
- Study aborted by the sponsor
Who can take part
- Age
- 21 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 38 criteriaShow less
Who can take part
- Age 21-80 years old
- Owns a smartphone that is an Android or iOS with a data plan
- Fluent in written and spoken English as the technology is currently only available in English
- Average of 3 BP readings in last 18 months of >140/90 OR last in-office BP >140/90 in the last 6 months as documented in their Electronic Health Record
- Is a patient with Providence Health
- Willing to attend the 2 in-person study visits
- Is not participating in another study that is designed to influence blood pressure
- Willing to wear the Aktiia bracelet for 6 months
- Willing to be randomized to either group
- Had a BMP in the last 12 months or is willing to get one at the discretion of the clinical pharmacist as standard of care
Who cannot take part
- Currently undergoing or will undergo active IV infusions for chemotherapy
- Tachycardia (heart rate at rest > 120bpm)
- Diabetes Mellitus
- Raynaud's disease
- Arteriovenous fistula
- Exfoliative skin disease
- Known allergy to silicone
- Terminal medical condition with a life expectancy less than 2 years
- Diagnosed whitecoat hypertension
- Any condition which, at the discretion of the enrolling investigator, would preclude their ability to comply with study procedures
- Cardiomyopathy with LVEF <40% documented within the past year
- CKD 4-5 (eGFR ≤ 30 mL/min)
- Blood pressure at the baseline in-office visit is too low (SBP <140 mmHg AND DBP <90 mmHg) OR is too high (SBP > 190 mmHg OR DBP > 120 mmHg)
- Atrial fibrillation, persistent or chronic
- Under active treatment for hyperthyroidism
- Myxedema coma
- Subclavian stenosis
- Pheochromocytoma
- Trembling and shivering
- Known pregnancy
- Breastfeeding
- Arm amputation
- Lymphedema
- Upper arm circumference < 22 cm or > 42 cm
- Wrist circumference < 14 cm or > 21 cm
- Adults unable to consent or who need a legally authorized representative to consent
- Currently incarcerated or detained in accordance with federal regulations regarding prisoners (e.g., 45 CFR 46 Subpart C)
- On hospice or going on hospice in the next 6-months
Where in United States
- Providence Health & ServicesPortland, United States
About the trial
What the trial wants to find out
The purpose of the CHANGE-BP study is to examine the change in in-office measured Blood Pressure (BP) from baseline to end of study (6-months) between participants randomized to either 1) Continual Blood Pressure Monitoring (CBPM), which includes receiving Aktiia's novel cuffless BP Research System that has an accompanying Aktiia Patient Interface smartphone application, and care delivered through a centralized Aktiia Provider Interface that displays device data and is accessible by a health care professional or 2) Home Blood Pressure Monitoring (HBPM), which includes a standard oscillometric blood pressure cuff and the standard blood pressure management care from a participant's primary care physician.
The 2 groups in the trial
- Continuous Blood Pressure Monitoring (CBPM)Treatment being tested
Participants will wear the Aktiia Bracelet for 6-months and potentially receive blood pressure medication titrations during the 6-month period.
Treatment: Aktiia Device
- Home Blood Pressure Monitoring (HBPM)Existing treatment, for comparison
Participants will receive an upper arm cuff and standard hypertension care from their primary care physician.
Treatment: Upper arm cuff
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 18 February 2025